Startup Revives Brain Activity for Drug Testing

A groundbreaking initiative by the American startup Bexorg is making waves in the medical and scientific fields. The company has successfully managed to maintain partial viability of deceased human brains, enabling unique opportunities for drug testing.

This innovative approach could revolutionize the way researchers evaluate the efficacy and safety of new pharmaceuticals, providing insights that were previously inaccessible.

As the implications for neuroscience and pharmacology unfold, Bexorg's work could pave the way for significant advancements in understanding brain function and drug interactions.